Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...

A first-of-its-kind study led by the Medical University of South Carolina raises questions about the value of fish oil ...

Robots can now turn plain language into real-world actions using a new framework that ...

Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...

What if sound waves succeed where drugs failed? Focused ultrasound shows promise in treating Alzheimer's-safe, effective, and ...